APOLLOTYRE.NS(APOLLOTYRE.NS)
APOLLOTYRE.NS
No analyst ratings available
No analyst price targets available for APOLLOTYRE.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $319.20B | $342.07B | $364.69B | $396.72B |
| Low | $310.32B | $327.96B | $346.35B | $381.61B |
| High | $328.02B | $360.09B | $381.70B | $413.33B |
| EBITDA Avg | $44.60B | $47.79B | $50.95B | $55.43B |
| Low | $43.36B | $45.82B | $48.39B | $53.32B |
| High | $45.83B | $50.31B | $53.33B | $57.75B |
| EBIT Avg | $25.56B | $27.39B | $29.20B | $31.77B |
| Low | $24.85B | $26.26B | $27.73B | $30.56B |
| High | $26.27B | $28.83B | $30.56B | $33.10B |
| Net Income Avg | $16.59B | $20.59B | $23.07B | $20.79B |
| Low | $13.76B | $18.49B | $19.40B | $19.76B |
| High | $20.51B | $24.56B | $25.09B | $21.92B |
| EPS Avg | $26.19 | $32.65 | $36.52 | $32.80 |
| Low | $21.71 | $29.16 | $30.61 | $31.18 |
| High | $32.36 | $38.75 | $39.58 | $34.59 |
| Analysts (Rev / EPS) | 20 / 20 | 21 / 20 | 8 / 5 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $76.61B | $84.42B | $79.13B |
| Low | $76.61B | $84.42B | $79.13B |
| High | $76.61B | $84.42B | $79.13B |
| EBITDA Avg | $10.70B | $11.80B | $11.06B |
| Low | $10.70B | $11.80B | $11.06B |
| High | $10.70B | $11.80B | $11.06B |
| EBIT Avg | $6.13B | $6.76B | $6.34B |
| Low | $6.13B | $6.76B | $6.34B |
| High | $6.13B | $6.76B | $6.34B |
| Net Income Avg | $4.26B | $4.23B | $4.43B |
| Low | $4.26B | $4.23B | $4.43B |
| High | $4.26B | $4.23B | $4.43B |
| EPS Avg | $6.72 | $6.68 | $7.00 |
| Low | $6.72 | $6.68 | $7.00 |
| High | $6.73 | $6.69 | $7.01 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |